Davidson Kempner Capital Management’s Boston Scientific BSX Stock Holding History

Davidson Kempner Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-63,250	Closed	-$3.97M	–	251
2026 Q1	$3.97M	Buy	+63,250	New	+$5.06M	0.05%	151
2020 Q3	–	Sell	-200,000	Closed	-$7.02M	–	269
2020 Q2	$7.02M	Buy	+200,000	New	+$7.2M	0.17%	126
2017 Q1	–	Sell	-600,000	Closed	-$13M	–	166
2016 Q4	$13M	Buy	600,000 +100,000	+20%	+$2.18M	0.26%	82
2016 Q3	$11.9M	Buy	500,000 +125,000	+33%	+$2.98M	0.29%	71
2016 Q2	$8.76M	Buy	+375,000	New	+$8.11M	0.21%	89

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Davidson Kempner Capital Management's BSX Position: Q2 2026 in Review

Davidson Kempner Capital Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 63,250 shares — an estimated $3.97M sold.

Davidson Kempner Capital Management first reported a position in BSX in Q2 2016 and held it in 5 quarters. The position peaked at $13M in Q4 2016. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Davidson Kempner Capital Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Davidson Kempner Capital Management sold 63,250 Boston Scientific shares in Q2 2026, an estimated $3.97M.
Davidson Kempner Capital Management first reported a position in Boston Scientific in Q2 2016 and held it in 5 quarters.
Davidson Kempner Capital Management's Boston Scientific position peaked at $13M in Q4 2016.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Davidson Kempner Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.